| Name | bepridil hydrochloride monohydrate |
|---|---|
| Synonyms |
3-isobutoxy-2-pyrrolidino-n-phenyl-n-benzylpropylaminehydrochloridehydrate
MFCD00065498 Unii-4W2p15D93m l)-,monohydrochloride,monohydrate angopril Bepridil hydrochloride,N-Benzyl-N-(3-isobutoxy-2-pyrrolidin-1-yl-propyl)anilinehydrochloride |
| Description | Bepridil hydrochloride hydrate ((±)-Bepridil hydrochloride hydrate) is a non-selective, long-acting Ca+ channel antagonist and Na+, K+ channel inhibitor, with antianginal and type I antiarrhythmic effects. Bepridil hydrochloride hydrate also acts as a cardiac Na+/Ca2+ exchange (NCX1) inhibitor. Bepridil hydrochloride hydrate can be used for the research of cardiovascular disorders[1][2][3][4][5]. |
|---|---|
| Related Catalog | |
| Target |
Ca2+ |
| In Vitro | Bepridil hydrochloride hydrate blockades of Ca2+-dependent action potentials in vascular smooth muscle of dog coronary artery[2]. Bepridil hydrochloride hydrate blocks Ca currents and Na currents with IC50s of 0.5 μM and 30 μM, respectively in cultured ventricular cells[4]. Bepridil hydrochloride hydrate decreases IKs under blockade of IKr with E4031 (5 μM), in a concentration-dependent manner[5]. |
| In Vivo | Bepridil hydrochloride hydrate exhibits a half-life of averages 33±15 hours after single-dose administration[6]. |
| References |
[1]. A Gill, et al. Pharmacology of Bepridil. Am J Cardiol. 1992 Apr 9;69(11):11D-16D. |
| Melting Point | 91 ±2° |
|---|---|
| Molecular Formula | C24H37ClN2O2 |
| Molecular Weight | 421.01600 |
| Exact Mass | 420.25400 |
| PSA | 24.94000 |
| LogP | 5.50580 |
| Appearance | powder | white |
| Storage condition | Desiccate at RT |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | UY1162000 |